Zahra Trippe
Seminars
Thursday 3rd December 2026
One Patient Strategy Doesn’t Fit All: Adapting Patient Engagement Across Diseases, Development Stages & Healthcare Systems
11:00 am
- Exploring how patient engagement strategies should evolve across different tumour types, therapeutic modalities and stages of radiopharmaceutical development, recognising that each programme presents unique patient needs and evidence requirements
- Sharing practical examples of how patient insights can strengthen early clinical development, clinical trial design, educational materials and regulatory interactions across diverse oncology indications
- Examining how patient engagement approaches should adapt as programmes progress from first-in-human studies through to late-stage clinical development, commercialisation and broader implementation
Wednesday 2nd December 2026
Integrating Radiopharmaceuticals into Standard of Care: Navigating Governance, Funding, Capacity, and Real-World Constraints
4:00 pm
- Identifying the key barriers to integrating radiopharmaceuticals into standard care, including governance, funding models, regulatory frameworks, and system complexity
- Exploring how healthcare systems, industry, and regulators can collaborate to enable coordinated, scalable integration within existing constraints
- Assessing the infrastructure, workforce, and operational capacity required to support demand, including planning for variability between projected and real-world volumes
